EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

FBXO39 promotes LDHA-mediated aerobic glycolysis and colorectal cancer progression by p53 degradation

Jipeng Liu, Taifu Xiao, Jun Huang

Journal of Translational Medicine · 01.04.2026 · 24 (1)

DOI: 10.1186/s12967-026-08056-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Translational Medicine, online erschienen am 01.04.2026. Verfasst von Jipeng Liu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi Province, 330…. Hauptthemen laut MEDLINE: Tumor Suppressor Protein p53, Colorectal Neoplasms, F-Box Proteins, Proteolysis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Colorectal cancer (CRC) is one of the leading causes of cancer-related deaths worldwide. Ubiquitination modification is extensively involved in various biological processes, including aerobic glycolysis and tumor development. TP53 mutations are present in nearly half of CRC patients, while in p53-wild type CRC, effective therapeutic targets remain relatively limited.

Methods

We employed bioinformatics methods to systematically analyze the expression and prognostic value of E3 ubiquitin ligase FBXO family members in CRC, with a focus on FBXO39. Through in vitro experiments such as CCK-8 assay, EdU cell proliferation assay, colony formation assay, glucose metabolite measurement, oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) analyses, as well as in vivo experiments including cell-derived xenograft models, we elucidated the biological functions of FBXO39 in CRC. Furthermore, we explored its molecular mechanisms through molecular docking, co-immunoprecipitation (Co-IP), and ubiquitination assays.

Results

FBXO39 expression was significantly higher in CRC tissues than in adjacent normal tissues, and its high expression was associated with poor patient prognosis. Functional experiments demonstrated that FBXO39 significantly promoted CRC cell proliferation both in vitro and in vivo. Mechanistically, FBXO39 directly bound to the p53 protein and promoted its ubiquitination-mediated degradation in p53-wild type CRC cells. Further investigations revealed that FBXO39 overexpression enhanced the aerobic glycolysis capacity of CRC cells, while its knockdown inhibited this process. Mechanistically, FBXO39 enhanced aerobic glycolysis and promoted tumor cell proliferation by upregulating lactate dehydrogenase A (LDHA) expression in a p53-dependent manner.

Conclusion

This study reveals a novel mechanism for p53 protein downregulation in p53-wild type CRC, elucidates the role of FBXO39 in regulating aerobic glycolysis through the p53/LDHA axis to promote tumor progression, and provides new insights into the function of FBXO39 in metabolic reprogramming in CRC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor Suppressor Protein p53Colorectal NeoplasmsF-Box ProteinsProteolysisDisease ProgressionGlycolysisLactate Dehydrogenase 5L-Lactate DehydrogenaseHumansAnimalsCell ProliferationCell Line, TumorUbiquitinationAerobiosisPrognosisMice, NudeGene Expression Regulation, NeoplasticProtein BindingMale

Stichwörter der Autor:innen

Aerobic glycolysisColorectal cancerFBXO39LDHAp53

Substanzen

Tumor Suppressor Protein p53F-Box ProteinsLactate Dehydrogenase 5LDHA protein, humanL-Lactate Dehydrogenase

Autor:innen und Institutionen

  • Department of Gastrointestinal Surgery, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi Province, 330006, PR China.
  • Precision Oncology Medicine Center, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi Province, 330006, PR China.
  • Department of Gastrointestinal Surgery, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi Province, 330006, PR China. huangjun@email.ncu.edu.cn.
  • Precision Oncology Medicine Center, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi Province, 330006, PR China. huangjun@email.ncu.edu.cn.

Zitieren

APA

Liu, J., Xiao, T., & Huang, J. (2026). FBXO39 promotes LDHA-mediated aerobic glycolysis and colorectal cancer progression by p53 degradation. Journal of Translational Medicine, 24(1). https://doi.org/10.1186/s12967-026-08056-7

Vancouver

Liu J, Xiao T, Huang J. FBXO39 promotes LDHA-mediated aerobic glycolysis and colorectal cancer progression by p53 degradation. Journal of Translational Medicine. 2026;24(1). doi:10.1186/s12967-026-08056-7

BibTeX
@article{Liu2026,
  author = {Liu, Jipeng and Xiao, Taifu and Huang, Jun},
  title = {FBXO39 promotes LDHA-mediated aerobic glycolysis and colorectal cancer progression by p53 degradation},
  journal = {Journal of Translational Medicine},
  year = {2026},
  volume = {24},
  number = {1},
  doi = {10.1186/s12967-026-08056-7}
}
Kostenlos starten →